002940.SZ Stock Analysis
00
Avoid
Based on Eyestock quantitative analysis, 002940.SZ`s fundamental data and valuation indicate an investment grade of Avoid at the current time.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Low score
Upside
To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.
Greatly undervalued
Zhejiang Anglikang Pharmaceutical Co., Ltd. engages in the research, development, production and sales of pharmaceutical drugs. The company is headquartered in Shaoxing, Zhejiang and currently employs 881 full-time employees. The company went IPO on 2018-10-23. is a China-based company principally engaged in the research, development, production and sales of chemical raw materials and preparations. The firm's products mainly include cephalosporin and penicillin series, anti-hypertension series, digestive system series, kidney disease series and others.